Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

The use of mirtazapine in difficult-to-treat patient populations.

The use of mirtazapine in difficult-to-treat patient populations. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • The use of mirtazapine in difficult-to-treat patient populations. Abstract Text:

    Patients who have failed previous antidepressant treatment present substantial clinical management challenges. Similarly, elderly patients require special attention. Three recent studies have shown that mirtazapine has a role to play in the management of these patients. Mirtazapine has proved effective in the treatment of patients who were resistant or intolerant to selective serotonin reuptake inhibitors (SSRIs) and the switch to mirtazapine could be made immediately without the necessity for a taper period. In a double-blind study in patients who were resistant to SSRI treatment, mirtazapine had a more rapid onset of action than sertraline. Mirtazapine has also proved effective in elderly depressed patients and again showed a faster onset of action than another of the SSRIs, paroxetine.

    The use of mirtazapine in difficult-to-treat patient populations. Publishing Authors By Initials

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    The use of mirtazapine in difficult-to-treat patient populations. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Human psychopharmacology

    VOLUME: 17 Suppl 1

    Page Numbers: S33-6

    Journal Abbreviation: Hum Psychopharmacol

    ISSN: 0885-6222

    DAY: 6

    MONTH: Jun

    YEAR: 2002

    The use of mirtazapine in difficult-to-treat patient populations. Information

    Number of References: 22

    LANGUAGE: eng

    NlmUniqueID: 8702539

    The use of mirtazapine in difficult-to-treat patient populations. Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: The use of mirtazapine in difficult-to-treat patient populations. Information

    Substance Name: mirtazapine

    Registry Number: 61337-67-5

    Grant and Affiliation Information for The use of mirtazapine in difficult-to-treat patient populations.

    AFFILIATION: University of Texas, Galveston, Texas, USA. rohirsch@utmb.edu

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hum Psychopharmacol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    The use of mirtazapine in difficult-to-treat patient populations Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News